ACLX
Price
$70.31
Change
+$0.41 (+0.59%)
Updated
Aug 27, 11:05 AM (EDT)
Capitalization
3.88B
82 days until earnings call
CGON
Price
$26.73
Change
-$0.30 (-1.11%)
Updated
Aug 27, 11:14 AM (EDT)
Capitalization
2.06B
83 days until earnings call
Interact to see
Advertisement

ACLX vs CGON

Header iconACLX vs CGON Comparison
Open Charts ACLX vs CGONBanner chart's image
Arcellx
Price$70.31
Change+$0.41 (+0.59%)
Volume$100
Capitalization3.88B
CG Oncology
Price$26.73
Change-$0.30 (-1.11%)
Volume$800
Capitalization2.06B
ACLX vs CGON Comparison Chart in %
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. CGON commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and CGON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (ACLX: $69.90 vs. CGON: $27.03)
Brand notoriety: ACLX and CGON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 67% vs. CGON: 103%
Market capitalization -- ACLX: $3.88B vs. CGON: $2.06B
ACLX [@Biotechnology] is valued at $3.88B. CGON’s [@Biotechnology] market capitalization is $2.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileCGON’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • CGON’s FA Score: 0 green, 5 red.
According to our system of comparison, ACLX is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while CGON’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 4 bearish.
  • CGON’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CGON is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а -2.92% price change this week, while CGON (@Biotechnology) price change was +5.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.95%. For the same industry, the average monthly price growth was +13.88%, and the average quarterly price growth was +31.15%.

Reported Earning Dates

ACLX is expected to report earnings on Nov 17, 2025.

CGON is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+3.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.88B) has a higher market cap than CGON($2.06B). CGON YTD gains are higher at: -5.753 vs. ACLX (-8.854). CGON has higher annual earnings (EBITDA): -157.09M vs. ACLX (-179.78M). CGON has more cash in the bank: 661M vs. ACLX (453M). CGON has less debt than ACLX: CGON (994K) vs ACLX (52.5M). ACLX has higher revenues than CGON: ACLX (57M) vs CGON (551K).
ACLXCGONACLX / CGON
Capitalization3.88B2.06B188%
EBITDA-179.78M-157.09M114%
Gain YTD-8.854-5.753154%
P/E RatioN/AN/A-
Revenue57M551K10,345%
Total Cash453M661M69%
Total Debt52.5M994K5,282%
TECHNICAL ANALYSIS
Technical Analysis
ACLXCGON
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 13 days ago
87%
Bullish Trend 6 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMPEX28.150.14
+0.50%
Beck Mack + Oliver Partners
HNCAX20.20N/A
N/A
Hartford International Growth A
FRDPX97.11N/A
N/A
Franklin Rising Dividends A
MARFX24.14N/A
N/A
BlackRock Mid-Cap Value Institutional
PSYGX83.57N/A
N/A
Putnam Small Cap Growth Y

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+2.06%
CGON - ACLX
56%
Loosely correlated
+6.33%
RNA - ACLX
55%
Loosely correlated
+3.93%
ROIV - ACLX
54%
Loosely correlated
+1.72%
XNCR - ACLX
53%
Loosely correlated
-1.37%
CRNX - ACLX
52%
Loosely correlated
+2.79%
More

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+6.33%
IDYA - CGON
61%
Loosely correlated
+0.61%
SYRE - CGON
60%
Loosely correlated
+2.90%
ACLX - CGON
57%
Loosely correlated
+2.06%
NUVL - CGON
55%
Loosely correlated
+1.19%
KYMR - CGON
55%
Loosely correlated
+4.90%
More